FEMASYS INC SEC filings

Filings

1. SCHEDULE 13GFEMASYS INCFEMY3d

   Femasys Inc. - Empery Asset Management reports 5.6% stake

   • Empery Asset Management, LP filed a Schedule 13G on 2026-10-15
   • Owns 5.6% of Femasys Inc. Common Stock
   • Based on 8,375,027 shares outstanding as of 2026-08-13

   Empery Asset Management, LP, filed by

2. 424B3FEMASYS INCFEMYSep 29

   Securities offering

3. EFFECTFEMASYS INCFEMYSep 29

   Registration declared effective

4. S-3FEMASYS INCFEMYSep 3

   Securities offering

5. SCHEDULE 13GFEMASYS INCFEMYAug 31

   Ownership stake disclosure by Stonepine Capital Management, LLC

   Stonepine Capital Management, LLC, filed by

6. DFEMASYS INCFEMYAug 20

   Private placement notice

7. SCHEDULE 13DFEMASYS INCFEMYAug 17

   Ownership stake disclosure by Nantahala Capital Partners Limited Partnership

   Nantahala Capital Partners Limited Partnership, filed by

8. 10-QFEMASYS INCFEMYAug 14

   Quarterly report

9. 8-KFEMASYS INCFEMYAug 14

   Current report

10. SCHEDULE 13GFEMASYS INCFEMYAug 14

    Ownership stake disclosure by Rosalind Advisors, Inc.

    Rosalind Advisors, Inc., filed by

11. 4FEMASYS INCFEMYAug 11

    11 insider filings

    Kenneth D. Eichenbaum, insider filing for FEMY

    Show all 11

    • 4Insider filing for FEMYAug 11
    • 4Insider filing for FEMYAug 11
    • 4Insider filing for FEMYAug 11
    • 4Insider filing for FEMYAug 11
    • 4Insider filing for FEMYAug 11
    • 4Insider filing for FEMYAug 11
    • 3New insider at FEMYAug 11
    • 4Insider filing for FEMYAug 11
    • 4Insider filing for FEMYAug 11
    • 4Insider filing for FEMYAug 11
    • 4Insider filing for FEMYAug 11

    Kenneth D. Eichenbaum, reporting

12. 8-KFEMASYS INCFEMYAug 11

    Current report

13. 8-KFEMASYS INCFEMYJun 24

    Current report

14. 8-KFEMASYS INCFEMYJun 24

    Current report

15. 8-KFEMASYS INCFEMYJun 5

    Current report

16. 8-KFEMASYS INCFEMYJun 4

    Current report

17. 8-KFEMASYS INCFEMYMay 13

    Current report

18. 10-QFEMASYS INCFEMYMay 8

    Quarterly report

19. 8-KFEMASYS INCFEMYMay 8

    Current report

20. DEF 14AFEMASYS INCFEMYApr 30

    Proxy statement

21. ARSFEMASYS INCFEMYApr 30

    Annual report to shareholders

22. DEFA14AFEMASYS INCFEMYApr 30

    Additional proxy materials

23. 8-KFEMASYS INCFEMYApr 29

    Current report

24. DEF 14AFEMASYS INCFEMYApr 6

    Proxy statement

25. 4FEMASYS INCFEMYApr 1

    2 insider filings

    John Charles Canning, insider filing for FEMY

    Show all 2

    • 4Insider filing for FEMYApr 1
    • 3New insider at FEMYApr 1

    John Charles Canning, reporting

26. 8-KFEMASYS INCFEMYApr 1

    Current report

27. S-8FEMASYS INCFEMYMar 31

    Employee stock plan registration

28. 10-KFEMASYS INCFEMYMar 31

    Annual report

29. 8-KFEMASYS INCFEMYMar 31

    Current report

30. 4FEMASYS INCFEMYMar 27

    4 insider filings

    Dov Elefant, insider filing for FEMY

    Show all 4

    • 4Insider filing for FEMYMar 27
    • 4Insider filing for FEMYMar 27
    • 4Insider filing for FEMYMar 27
    • 4Insider filing for FEMYMar 27

    Dov Elefant, reporting

31. PRE 14AFEMASYS INCFEMYMar 27

    Preliminary proxy statement

32. 3FEMASYS INCFEMYMar 24

    Kenneth D. Eichenbaum, new insider at FEMY

    Kenneth D. Eichenbaum, reporting

33. 4FEMASYS INCFEMYMar 20

    Kenneth D. Eichenbaum, insider filing for FEMY

    Kenneth D. Eichenbaum, reporting

34. 8-KFEMASYS INCFEMYMar 20

    Current report

35. 4FEMASYS INCFEMYMar 18

    2 insider filings

    PharmaCyte Biotech, Inc., insider filing for FEMY

    Show all 2

    • 4Insider filing for FEMYMar 18
    • 4Insider filing for FEMYMar 18

    PharmaCyte Biotech, Inc., reporting

Older filings on EDGAR